Literature DB >> 20226386

Conditional transformation of immunoglobulin mutation pattern from gene conversion into point mutation by controlling XRCC3 expression in the DT40 B cell line.

Masamichi Kajita1, Masaki Magari, Kagefumi Todo, Naoki Kanayama, Hitoshi Ohmori.   

Abstract

A hypermutating B cell line DT40 is useful for screening antibodies and improving affinity of the selected antibodies in vitro. To perform affinity maturation efficiently, we generated an engineered DT40 line whose immunoglobulin mutation pattern can be transformed from gene conversion into point mutation by conditional suppression of XRCC3 expression. Copyright 2009 The Society for Biotechnology, Japan. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20226386     DOI: 10.1016/j.jbiosc.2009.09.050

Source DB:  PubMed          Journal:  J Biosci Bioeng        ISSN: 1347-4421            Impact factor:   2.894


  4 in total

1.  Interaction of DNA repair gene polymorphisms and aflatoxin B1 in the risk of hepatocellular carcinoma.

Authors:  Jin-Guang Yao; Xiao-Ying Huang; Xi-Dai Long
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

2.  Antibody discovery ex vivo accelerated by the LacO/LacI regulatory network.

Authors:  Munehisa Yabuki; W Jason Cummings; John B Leppard; Robert M Immormino; Christi L Wood; Daniel S Allison; Patrick W Gray; Larry W Tjoelker; Nancy Maizels
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

3.  B-cell display-based one-step method to generate chimeric human IgG monoclonal antibodies.

Authors:  Waka Lin; Kohei Kurosawa; Akiho Murayama; Eri Kagaya; Kunihiro Ohta
Journal:  Nucleic Acids Res       Date:  2010-11-09       Impact factor: 16.971

4.  A genome-wide association study for natural antibodies measured in blood of Canadian Holstein cows.

Authors:  Britt de Klerk; Mehdi Emam; Kathleen A Thompson-Crispi; Mehdi Sargolzaei; Johan J van der Poel; Bonnie A Mallard
Journal:  BMC Genomics       Date:  2018-09-21       Impact factor: 3.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.